Ebola vaccine doses arrive in DRC
The Democratic Republic of the Congo received its first batch of over 16,000 doses of the "Ervebo" Ebola vaccine as part of urgent international efforts to contain the seventeenth outbreak of the disease, which is the deadliest in the country's history. The vaccination campaign, which includes some doses allocated for clinical trials and healthcare workers, aims to combat the spread of the virus in the northern and eastern regions where cases are rising. This is challenging due to the lack of healthcare infrastructure and support from armed groups. The World Health Organization is adopting a plan to expand the vaccine trial, which has proven effective against the Zaire strain, in the hope of providing protection against the current Bundibugyo strain, while ongoing development of new vaccines by global companies continues.
Notice: This Is an AI-Generated Summary
Comments (0)